Referred to the House Committee on Energy and Commerce.
This bill would require mifepristone labeling to include a conspicuous warning that its effects can be counteracted by natural progesterone and list a 24/7 hotline number. It also directs the Department of Health and Human Services to establish or maintain a toll-free hotline that provides support and referrals specifically to providers offering abortion pill reversal services.
Progressives emphasize medical misinformation and autonomy risks.
Relative to its intended legislative type, this bill successfully specifies two discrete statutory changes—a required warning label for mifepristone (with exact text) and creation of a 24/7 hotline under the PHSA—thereby performing the core tasks of a substantive policy change.
This bill would require mifepristone labeling to include a conspicuous warning that its effects can be counteracted by natural progesterone and list a 24/7 hotline number.
It also directs the Department of Health and Human Services to establish or maintain a toll-free hotline that provides support and referrals specifically to providers offering abortion pill reversal services.
The labeling requirement becomes effective six months after enactment.
Narrow scope helps, but high controversy, likely Senate obstacles, potential legal and scientific disputes reduce overall odds.
Relative to its intended legislative type, this bill successfully specifies two discrete statutory changes—a required warning label for mifepristone (with exact text) and creation of a 24/7 hotline under the PHSA—thereby performing the core tasks of a substantive policy change. However, its construction omits multiple practical and legal details that would normally accompany such changes.
Progressives emphasize medical misinformation and autonomy risks.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize medical misinformation and autonomy risks.
Likely to view the bill as medically misleading and politically motivated.
Concern centers on statutory labeling and a government-funded hotline promoting an unproven clinical intervention and potentially undermining reproductive autonomy.
Pragmatic skepticism: values informed choice but wants medical accuracy and minimal government overreach.
May support a neutral, evidence-reviewed information channel but opposes mandatory, one-sided statutory claims.
Likely to view the bill positively as expanding options to preserve pregnancies and inform patients.
Sees government role as providing information and facilitating access to reversal services.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow scope helps, but high controversy, likely Senate obstacles, potential legal and scientific disputes reduce overall odds.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize medical misinformation and autonomy risks.
Narrow scope helps, but high controversy, likely Senate obstacles, potential legal and scientific disputes reduce overall odds.
Relative to its intended legislative type, this bill successfully specifies two discrete statutory changes—a required warning label for mifepristone (with exact text) and creation of a 24/7 hotline under the PHSA—thereb…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.